You are here: vision-research.eu » People » Research Groups » United Kingdom » Coupland, Sarah

Liverpool Ocular Oncology Research Group (LOORG)

The Liverpool Ocular Oncology Research Group’s (LOORG’s) mission is to conduct high quality basic, translational and clinical research into the pathogenesis and treatment of adult ocular tumours that will improve patient care and survival. The Liverpool Ocular Oncology Research Group (LOORG) was established by Professor Sarah Coupland and Professor Bertil Damato in 2006. Prof. Coupland has since lead the basic science and translational research portfolio, in addition to being a Consultant Pathologist at the Royal Liverpool University Hospital.

A major strength of the LOORG is the close collaboration between ocular oncology clinicians (Lead, Professor Heimann), pathologists and basic scientists (Dr Sarah Lake and Dr Helen Kalirai) which ensures that the research we conduct addresses the key questions that will bring about improved survival and quality of life for ocular oncology patients.

Group Leader

Sarah E. Coupland
[more information]

Contact

University of Liverpool

Molecular and Clinical Cancer Medicine
Institute of Translational Medicine
6th Floor, Duncan Building
L69 3GA Liverpool
United Kingdom

Phone: +44(0)151 706 4494
Fax: +44(0)151 706 5826

E-mail:
s.e.coupland[at]liverpool.ac.uk

Website:
www.loorg.org

Current Research Projects

  • Project 1:
    Identification of regulators of metastasis in uveal melanoma
  • Project 2:
    Proteomic discovery of serum biomarkers in metastatic uveal melanoma
  • Project 3:
    Estimating survival prognosis after treatment of choroidal melanoma
  • Project 4:
    Gross chromosomal abnormalities in iris melanoma
  • Project 5:
    Molecular characteristics of metastatic liver lesions in uveal melanoma: the search for therapeutic targets

Research Groups

People

Related Research Groups

clinical laboratory testing
Oops, an error occurred! Code: 20191017031724dc788e21
conjunctiva
Oops, an error occurred! Code: 20191017031724245a15be
disease gene mapping
Oops, an error occurred! Code: 20191017031724f2a11dbb
gene/expression
Oops, an error occurred! Code: 20191017031724d4585964
gene microarray
Oops, an error occurred! Code: 20191017031724c6fe994b
genetics
Oops, an error occurred! Code: 20191017031724d2942ceb
immunohistochemistry
Oops, an error occurred! Code: 20191017031724133fb5c0
iris
Oops, an error occurred! Code: 20191017031724554ab628
melanoma
Oops, an error occurred! Code: 201910170317249d96e9ae
oncology
Oops, an error occurred! Code: 201910170317245d0f4f1f
pathology: experimental
Oops, an error occurred! Code: 2019101703172419720a64
pathology: human
Oops, an error occurred! Code: 20191017031724139d2367
pathology techniques
Oops, an error occurred! Code: 201910170317246832b71b
tumors
Oops, an error occurred! Code: 2019101703172421c68bb4
uvea
Oops, an error occurred! Code: 20191017031724c982b7f4
vision and action
Oops, an error occurred! Code: 20191017031724c7234d6d
visual acuity
Oops, an error occurred! Code: 201910170317244d20c821
uveal melanoma
Oops, an error occurred! Code: 201910170317240b3d5c98
conjunctival melanoma
Oops, an error occurred! Code: 201910170317242199f76b
intraocular and ocular adnexal lymphomas
Oops, an error occurred! Code: 20191017031724fb09259b
pathology
Oops, an error occurred! Code: 20191017031724bed90ca2
translational studies
Oops, an error occurred! Code: 20191017031724bcd63856